Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Fellowships: Epidemiology and Population Sciences.                    

*Date:*                         November 14-15, 2024.                    

*Time:*                         9 a.m. to 8 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         St. Gregory Hotel, 2033 M Street NW, Washington, DC 20036.                    

*Meeting Format:*                         In Person.                    

*Contact Person:*                         Rebecca I. Tinker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 435-0637,                         *tinkerri@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; PAR-24-202: Lasker Clinical Research Scholars Program.                    

*Date:*                         November 15, 2024.                    

*Time:*                         9 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Yue Wu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 803C, Bethesda, MD 20892, (301) 867-5309,                         *wuy25@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurotechnology and Neuroengineering.                    

*Date:*                         November 15, 2024.                    

*Time:*                         9 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Cibu Paul Thomas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of                               ( print page 85226)                            Health, 6701 Rockledge Drive, Room 1011-H, Bethesda, MD 20894, (301) 402-4341,                         *thomascp@mail.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Study In Cancer Biology Area Review.                    

*Date:*                         November 15, 2024.                    

*Time:*                         11 a.m. to 8 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Charles Morrow, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 20892, 301-408-9850,                         *morrowcs@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; AREA/REAP: Respiratory, Cardiac and Circulatory Sciences.                    

*Date:*                         November 15, 2024.                    

*Time:*                         1 p.m. to 7 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Kirk E. Dineley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 806E, Bethesda, MD 20892, (301) 867-5309,                         *dineleyke@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Small Business: The Cancer Biotherapeutics Development (CBD).                    

*Date:*                         November 18-19, 2024.                    

*Time:*                         9 a.m. to 7 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Laurie Ann Shuman Moss, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,                         *laurie.shumanmoss@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Clinical Data Management and Analysis/Clinical Informatics and Digital Health Special Emphasis Panel.                    

*Date:*                         November 18-19, 2024.                    

*Time:*                         9 a.m. to 8 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Amy Kathleen Wernimont, BS, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301-827-6427,                         *amy.wernimont@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; PAR Panel: Metabolic, Cerebrovascular, Environmental, and Sleep Factors in Alzheimer's Disease and Related Dementias (ADRD).                    

*Date:*                         November 18-19, 2024.                    

*Time:*                         9 a.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Jennifer Kielczewski, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,                         *jennifer.kielczewski@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Small Business: The Cancer Drug Development and Therapeutics (CDDT).                    

*Date:*                         November 18-19, 2024.                    

*Time:*                         9 a.m. to 8 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Lilia Topol, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-0131,                         *ltopol@mail.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; PAR-22-180: Maximizing Investigators' Research Award.                    

*Date:*                         November 18, 2024.                    

*Time:*                         9:30 a.m. to 8 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Mollie Kim Manier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510,                         *mollie.manier@nih.gov.*

*Name of Committee:*                         Risk, Prevention and Health Behavior Integrated Review Group; HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section.                    

*Date:*                         November 18-19, 2024.                    

*Time:*                         10 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Mark P. Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-806-6596,                         *rubertm@csr.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: October 21, 2024.

David W. Freeman,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-24878 Filed 10-24-24; 8:45 am]

BILLING CODE 4140-01-P